ArticleCell death discovery2026

PER2 reprograms intracellular cholesterol synthesis to inhibit oral squamous cell carcinoma and the chronotherapeutic efficacy of simvastatin.

Shilin Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.